PHAT
Phathom Pharmaceuticals Inc. (PHAT)
NASDAQ · Healthcare
Phathom Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Phathom Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 58.3 M, a 104.43% increase year-over-year.
- Phathom Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 175.8 M, a 587.15% increase year-over-year.
- Phathom Pharmaceuticals Inc. annual revenue for 2025 was 175.1 M, a 216.93% increase from 2024.
- Phathom Pharmaceuticals Inc. annual revenue for 2024 was 55.3 M, a 8001.47% increase from 2023.
- Phathom Pharmaceuticals Inc. annual revenue for 2023 was 682000.
- Phathom Pharmaceuticals Inc. annual revenue for 2022 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Phathom Pharmaceuticals Inc. Earnings — FAQ
Phathom Pharmaceuticals Inc. (PHAT) earnings over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PHAT's earnings history?
The chart and table above show Phathom Pharmaceuticals Inc.'s earnings by year and by quarter, including the growth rate.